Four-Year Prospective Clinical Trial of Agalsidase Alfa in Children with Fabry Disease

CDC GROWTH CHARTS FOR THE UNITED STATES: METHODS AND DEVELOPMENT 2000

Robert J. Kuczmarski, Cynthia L. Ogden, S. S. Guo et al. · 2002 · 6.5K citations

Public Health, Population Health Sciences, Disease Surveillance +15

Pain assessment: global use of the Brief Pain Inventory.

Cleeland Cs, Ryan Km · PubMed · 1994 · 5.3K citations

Medicine, Oncology, Cancer Pain Management +10

Safety and Efficacy of Recombinant Human α-Galactosidase A Replacement Therapy in Fabry's Disease

Christine M. Eng, Nathalie Guffon, William R. Wilcox et al. · New England Journal of Medicine · 2001 · 1.5K citations · Full text

Medicine, Clinical Sciences, Pharmacology +14

Enzyme Replacement Therapy in Fabry Disease

Raphael Schiffmann, Jeffrey B. Kopp, Howard A. Austin et al. · JAMA · 2001 · 1.3K citations

Medicine, Pharmacology, Pharmacotherapy +13

Enzymatic Defect in Fabry's Disease

Roscoe O. Brady, Andrew E. Gal, Roy M. Bradley et al. · New England Journal of Medicine · 1967 · 1.1K citations

Life Sciences, Biochemistry, Dermatology +12